Telesis Bio, Inc.
NASDAQ:TBIO
Overview | Financials
Company Name | Telesis Bio, Inc. |
Symbol | TBIO |
Currency | USD |
Price | 1.11 |
Market Cap | 1,967,975 |
Dividend Yield | 0% |
52-week-range | 1.11 - 15.462 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Todd R. Nelson MBA, Ph.D. |
Website | https://codexdna.com |
An error occurred while fetching data.
About Telesis Bio, Inc.
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD